Texas Diabetes & Endocrinology

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Type 1 diabetes3 trials
• Type 2 diabetes3 trials

Phase

• Phase 23 trials
• Phase 31 trial

Status

• Completed4 trials
• Withdrawn1 trial

Lead sponsor

• Novo Nordisk A/S2 trials
• Biomea Fusion Inc.1 trial
• Diasome Pharmaceuticals1 trial
• Medtronic MiniMed, Inc.1 trial

Closed trials

• Withdrawn

  SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT06719531· Medtronic MiniMed, Inc.· Source

• Completed

  Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

  NCT06152042· Phase 2· Biomea Fusion Inc.· Source

• Completed

  Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

  NCT06238778· Phase 2· Diasome Pharmaceuticals· Source

• Completed

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

  NCT05352815· Phase 3· Novo Nordisk A/S· Source

• Completed

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· Phase 2· Novo Nordisk A/S· Source